Market Overview:
The global sexually transmitted disease (STD) diagnosis market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of STDs, growing awareness about STDs and their prevention, and technological advancements in the field of STD diagnosis. The sexually transmitted disease (STD) diagnosis market is segmented on the basis of type into chlamydia testing, syphilis testing, gonorrhoea testing, herpes simplex virus testing, human papilloma virus (HPV)testing and human immunodeficiency virus (HIV)testing. Chlamydia Testing is expected to account for the largest share of the global STD diagnosis market in 2018 owing to its high prevalence among people aged 15-24 years. Gonorrhoea Testing is projected to grow at a highest CAGR during forecast period due to increasing incidence rates globally.
 Diagnosis Industry Outlook.svg)
Product Definition:
A sexually transmitted disease (STD) is a disease that can be passed from one person to another through sexual contact. STDs can affect men and women of all ages and backgrounds. Some STDs, such as HIV, are life-threatening. It is important for people who are sexually active to get tested for STDs on a regular basis.
Chlamydia testing:
Chlamydia is a common bacterial infection of the reproductive organs and urinary tract. It is also known as “clap” or “chlamydia trachomatis”. The disease can be transmitted through direct contact with an infected partner, via oral, vaginal or anal sex. According to CDC (Centers for Disease Control and Prevention), around 2 million new cases of chlamydia are diagnosed in the U.
Syphilis testing:
Syphilis testing is used in the diagnosis of diseases such as syphilis, a sexually transmitted disease. Syphilis can affect the skin, bones, and joints and may lead to serious complications if not diagnosed at an early stage. The disease has two major stages-primary and secondary. Primary syphilis involves only one stage while secondary syphilis includes two or more stages that usually start with pain in extremities, muscle aches, fatigue, loss of appetite along with a rash on the body.
Application Insights:
The government organizations application segment held the largest share of over 60.0% in 2017. The increasing prevalence of STDs, especially among youth and young adults, is one of the major factors contributing to the large share held by this segment. According to a study published in CDC journal in 2015, found that about 1 in 5 women and 1 in 6 men between ages 15-24 have been exposed to HIV through sexual contact; additionally, about 2 out of 3 new infections are occurring among African American youth and young adults between 15-24 years.
Regional Analysis:
North America dominated the global sexually transmitted disease diagnosis market in 2017. This can be attributed to rising awareness about STD prevention, increasing government initiatives for testing and treatment, and presence of well-established healthcare facilities in this region. For instance, as per a WHO fact sheet published in March 2018 titled “Syphilis Testing & Treatmentâ€; syphilis is treated with two different antibiotics: penicillin or doxycycline.
In addition to this, the availability of advanced diagnostic tools and high prevalence of STDs are some other factors contributing toward its dominance during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period owing to growing awareness about various sexually transmitted diseases (STD), increase in government initiatives for their treatment & control programs along with an increase number of patients seeking medical help for these conditions especially due to lack of knowledge regarding early diagnosis which may result ultimately leads into severe consequences such as infertility or death etc.
Growth Factors:
- Increasing incidence of STDs: The increasing incidence of STDs is one of the major growth drivers for the STD diagnosis market. According to the Centers for Disease Control and Prevention (CDC), there are approximately 20 million new cases of sexually transmitted infections (STIs) in the United States every year. This high incidence rate is a major concern, as it can lead to serious health complications if left untreated.
- Growing awareness about STDs: The growing awareness about STDs is another key growth driver for the STD diagnosis market. There has been a significant increase in public awareness about these diseases in recent years, owing to campaigns by various government and non-government organizations. This increased awareness has led to an increase in demand for diagnostic tests for early detection and treatment of these diseases.
- Technological advancements: The advent of new technologies such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) has revolutionized the field of STD diagnosis, making it easier than ever before to detect even minor traces of these infections accurately and quickly. This technological progress is likely to drive demand for STD diagnostic tests in coming years, thereby contributing to market growth."
Scope Of The Report
Report Attributes
Report Details
Report Title
Sexually Transmitted Disease (STD) Diagnosis Market Research Report
By Type
Chlamydia testing, Syphilis testing, Gonorrhoea testing, Herpes simplex virus testing, Human papilloma virus testing, Human immunodeficiency virus testing
By Application
Government organizations, Hospitals, Diagnostic clinics
By Companies
Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux, Bio-Rad, Cepheid, Danaher, DiaSorin, Quidel, GenMark Diagnostics, Hologic, OraSure Technologies, Qualigen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Sexually Transmitted Disease (STD) Diagnosis Market Report Segments:
The global Sexually Transmitted Disease (STD) Diagnosis market is segmented on the basis of:
Types
Chlamydia testing, Syphilis testing, Gonorrhoea testing, Herpes simplex virus testing, Human papilloma virus testing, Human immunodeficiency virus testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Government organizations, Hospitals, Diagnostic clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- Thermo Fisher Scientific
- Aposcience
- BCR Diagnostics
- BD Medical
- Biocartis
- BioMerieux
- Bio-Rad
- Cepheid
- Danaher
- DiaSorin
- Quidel
- GenMark Diagnostics
- Hologic
- OraSure Technologies
- Qualigen
 Diagnosis Market Overview.svg)
Highlights of The Sexually Transmitted Disease (STD) Diagnosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chlamydia testing
- Syphilis testing
- Gonorrhoea testing
- Herpes simplex virus testing
- Human papilloma virus testing
- Human immunodeficiency virus testing
- By Application:
- Government organizations
- Hospitals
- Diagnostic clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sexually Transmitted Disease (STD) Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Diagnosis Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
STD diagnosis is the process of determining if a person has an STD. This can be done through a physical examination, testing for antibodies against certain STDs, or using DNA tests.
Some of the major players in the sexually transmitted disease (std) diagnosis market are Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux, Bio-Rad, Cepheid, Danaher, DiaSorin, Quidel, GenMark Diagnostics, Hologic, OraSure Technologies, Qualigen.
The sexually transmitted disease (std) diagnosis market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sexually Transmitted Disease (STD) Diagnosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sexually Transmitted Disease (STD) Diagnosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sexually Transmitted Disease (STD) Diagnosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sexually Transmitted Disease (STD) Diagnosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sexually Transmitted Disease (STD) Diagnosis Market Size & Forecast, 2020-2028
4.5.1 Sexually Transmitted Disease (STD) Diagnosis Market Size and Y-o-Y Growth
4.5.2 Sexually Transmitted Disease (STD) Diagnosis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chlamydia testing
5.2.2 Syphilis testing
5.2.3 Gonorrhoea testing
5.2.4 Herpes simplex virus testing
5.2.5 Human papilloma virus testing
5.2.6 Human immunodeficiency virus testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Government organizations
6.2.2 Hospitals
6.2.3 Diagnostic clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sexually Transmitted Disease (STD) Diagnosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chlamydia testing
9.6.2 Syphilis testing
9.6.3 Gonorrhoea testing
9.6.4 Herpes simplex virus testing
9.6.5 Human papilloma virus testing
9.6.6 Human immunodeficiency virus testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Government organizations
9.10.2 Hospitals
9.10.3 Diagnostic clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chlamydia testing
10.6.2 Syphilis testing
10.6.3 Gonorrhoea testing
10.6.4 Herpes simplex virus testing
10.6.5 Human papilloma virus testing
10.6.6 Human immunodeficiency virus testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Government organizations
10.10.2 Hospitals
10.10.3 Diagnostic clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chlamydia testing
11.6.2 Syphilis testing
11.6.3 Gonorrhoea testing
11.6.4 Herpes simplex virus testing
11.6.5 Human papilloma virus testing
11.6.6 Human immunodeficiency virus testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Government organizations
11.10.2 Hospitals
11.10.3 Diagnostic clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chlamydia testing
12.6.2 Syphilis testing
12.6.3 Gonorrhoea testing
12.6.4 Herpes simplex virus testing
12.6.5 Human papilloma virus testing
12.6.6 Human immunodeficiency virus testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Government organizations
12.10.2 Hospitals
12.10.3 Diagnostic clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chlamydia testing
13.6.2 Syphilis testing
13.6.3 Gonorrhoea testing
13.6.4 Herpes simplex virus testing
13.6.5 Human papilloma virus testing
13.6.6 Human immunodeficiency virus testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Government organizations
13.10.2 Hospitals
13.10.3 Diagnostic clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sexually Transmitted Disease (STD) Diagnosis Market: Competitive Dashboard
14.2 Global Sexually Transmitted Disease (STD) Diagnosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Roche
14.3.3 Thermo Fisher Scientific
14.3.4 Aposcience
14.3.5 BCR Diagnostics
14.3.6 BD Medical
14.3.7 Biocartis
14.3.8 BioMerieux
14.3.9 Bio-Rad
14.3.10 Cepheid
14.3.11 Danaher
14.3.12 DiaSorin
14.3.13 Quidel
14.3.14 GenMark Diagnostics
14.3.15 Hologic
14.3.16 OraSure Technologies
14.3.17 Qualigen
